Healthcare / Medical DistributionXETRA
$19.58
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $29.8M · quality 75.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
79/100
B
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$368M
P/E
16.5x
↓EV/EBITDA
8.7x
↓ROE
18.5%
↑Gross Margin
22.7%
↓Debt/Equity
0.06
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+8.5%
FCF CAGR
+25.8%
FCF margin
10.4%
FCF / Net income
1.71x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $364.3M · net income $22.1M · FCF $37.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $364.3M | $364.3M | $339.2M | $316.3M | $285.3M |
| Net Income | $22.1M | $22.1M | $16.0M | $10.3M | $4.3M |
| EBITDA | $40.5M | $40.5M | $33.4M | $23.1M | $17.1M |
| EPS | 1.19 | 1.19 | 0.85 | 0.54 | 0.24 |
| Gross Margin | 22.7% | 22.7% | 18.8% | 15.9% | 18.5% |
| Operating Margin | 10.1% | 10.1% | 7.7% | 4.6% | 3.1% |
| Net Margin | 6.1% | 6.1% | 4.7% | 3.2% | 1.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.06 | 0.06 | 0.10 | 0.10 | 0.14 |
| Current Ratio | 2.82 | 2.82 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $37.8M | $37.8M | $29.8M | $6.8M | $19.0M |
| Returns | |||||
| ROE | 18.5% | 18.5% | 15.1% | 9.1% | 4.5% |
| Valuation | |||||
| P/E | 16.45 | 16.45 | 19.65 | 19.91 | 33.67 |
| EV/EBITDA | 8.74 | 8.74 | 9.50 | 8.64 | 8.02 |
| P/B | 3.21 | 3.21 | 3.09 | 1.86 | 1.66 |
| Growth & Yield | |||||
| Revenue Growth | 7.4% | 7.4% | 7.2% | 10.9% | — |
| EPS Growth | 40.0% | 40.0% | 57.4% | 125.0% | — |
| Dividend Yield | 6.3% | 6.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
13.4%
EPS terminal req.
$1.74
Spread vs growth
26.6%
5Y implied EPS CAGR
12.1%
EPS terminal req.
$2.10
Spread vs growth
27.9%
10Y implied EPS CAGR
11.0%
EPS terminal req.
$3.39
Spread vs growth
29.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+35.6%
Start / end P/E
17.3x → 16.0x
EPS bridge
0.85 → 1.19
Residual
-3.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.